These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24018533)

  • 21. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.
    Valmori D; Souleimanian NE; Tosello V; Bhardwaj N; Adams S; O'Neill D; Pavlick A; Escalon JB; Cruz CM; Angiulli A; Angiulli F; Mears G; Vogel SM; Pan L; Jungbluth AA; Hoffmann EW; Venhaus R; Ritter G; Old LJ; Ayyoub M
    Proc Natl Acad Sci U S A; 2007 May; 104(21):8947-52. PubMed ID: 17517626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.
    Preynat-Seauve O; Contassot E; Schuler P; French LE; Huard B
    Melanoma Res; 2007 Jun; 17(3):169-76. PubMed ID: 17505262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helping themselves: optimal virus-specific CD4 T cell responses require help via CD4 T cell licensing of dendritic cells.
    Olson MR; Seah SG; Cullen J; Greyer M; Edenborough K; Doherty PC; Bedoui S; Lew AM; Turner SJ
    J Immunol; 2014 Dec; 193(11):5420-33. PubMed ID: 25339661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-priming of cyclin B1, MUC-1 and survivin-specific CD8+ T cells by dendritic cells loaded with killed allogeneic breast cancer cells.
    Saito H; Dubsky P; Dantin C; Finn OJ; Banchereau J; Palucka AK
    Breast Cancer Res; 2006; 8(6):R65. PubMed ID: 17129372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo.
    van Montfoort N; Mangsbo SM; Camps MG; van Maren WW; Verhaart IE; Waisman A; Drijfhout JW; Melief CJ; Verbeek JS; Ossendorp F
    Eur J Immunol; 2012 Mar; 42(3):598-606. PubMed ID: 22488363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired cross-presentation of CD8α+ CD11c+ dendritic cells by Japanese encephalitis virus in a TLR2/MyD88 signal pathway-dependent manner.
    Aleyas AG; Han YW; Patil AM; Kim SB; Kim K; Eo SK
    Eur J Immunol; 2012 Oct; 42(10):2655-66. PubMed ID: 22706912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
    Lund AW; Duraes FV; Hirosue S; Raghavan VR; Nembrini C; Thomas SN; Issa A; Hugues S; Swartz MA
    Cell Rep; 2012 Mar; 1(3):191-9. PubMed ID: 22832193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells.
    Langlois RA; Legge KL
    J Immunol; 2010 Apr; 184(8):4440-6. PubMed ID: 20220091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.
    Tsuji T; Matsuzaki J; Kelly MP; Ramakrishna V; Vitale L; He LZ; Keler T; Odunsi K; Old LJ; Ritter G; Gnjatic S
    J Immunol; 2011 Jan; 186(2):1218-27. PubMed ID: 21149605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG promotes cross-presentation of dead cell-associated antigens by pre-CD8α+ dendritic cells [corrected].
    de Brito C; Tomkowiak M; Ghittoni R; Caux C; Leverrier Y; Marvel J
    J Immunol; 2011 Feb; 186(3):1503-11. PubMed ID: 21187449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 May; 31(5):1523-30. PubMed ID: 11465109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior exposure to inhaled allergen enhances anti-viral immunity and T cell priming by dendritic cells.
    Lee DCP; Tay NQ; Thian M; Prabhu N; Furuhashi K; Kemeny DM
    PLoS One; 2018; 13(1):e0190063. PubMed ID: 29293541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections.
    Crowe SR; Turner SJ; Miller SC; Roberts AD; Rappolo RA; Doherty PC; Ely KH; Woodland DL
    J Exp Med; 2003 Aug; 198(3):399-410. PubMed ID: 12885871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
    Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD154+ CD4+ T-cell dependence for effective memory influenza virus-specific CD8+ T-cell responses.
    Olson MR; Seah SG; Edenborough K; Doherty PC; Lew AM; Turner SJ
    Immunol Cell Biol; 2014 Aug; 92(7):605-11. PubMed ID: 24777309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1R signaling in dendritic cells replaces pattern-recognition receptors in promoting CD8⁺ T cell responses to influenza A virus.
    Pang IK; Ichinohe T; Iwasaki A
    Nat Immunol; 2013 Mar; 14(3):246-53. PubMed ID: 23314004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptide.
    Ikeuchi N; Futami J; Hosoi A; Noji S; Kurachi M; Ueha S; Fujii S; Yamada H; Matsushima K; Moriyasu F; Kakimi K
    Biochem Biophys Res Commun; 2010 Feb; 392(2):217-22. PubMed ID: 20067764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.
    Silva M; Silva Z; Marques G; Ferro T; Gonçalves M; Monteiro M; van Vliet SJ; Mohr E; Lino AC; Fernandes AR; Lima FA; van Kooyk Y; Matos T; Tadokoro CE; Videira PA
    Oncotarget; 2016 Jul; 7(27):41053-41066. PubMed ID: 27203391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.